Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06590961
Title UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ubix Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL

Facility Status City State Zip Country Details
University of Michigan NOT_YET_RECRUITING Ann Arbor Michigan 48109 United States Details
Gabrail Cancer Center RECRUITING Canton Oklahoma 44718 United States Details
MD Anderson Cancer Center NOT_YET_RECRUITING Houston Texas 77030 United States Details
Asan Medical Center NOT_YET_RECRUITING Seoul 05505 Korea, Republic of Details
Samsung Medical Center NOT_YET_RECRUITING Seoul 06351 Korea, Republic of Details
The Catholic University of Korea, Seoul St. Mary's Hospital NOT_YET_RECRUITING Seoul 06591 Korea, Republic of Details
The Catholic University of Korea, Yeouido St. Mary's Hospital NOT_YET_RECRUITING Seoul 07345 Korea, Republic of Details
MICS Centrum Medyczne Toruń NOT_YET_RECRUITING Toruń Kuyavian-Pomeranian Voivodeship 87-100 Poland Details
Pratia, MTZ Clinical Research NOT_YET_RECRUITING Warsaw Mazowieckie Voivodeship 02-172 Poland Details
Pratia, Oncology Katowice NOT_YET_RECRUITING Katowice Silesian Voivodeship 40-519 Poland Details
AidPort NOT_YET_RECRUITING Grodzisk Wielkopolski Wielkopolskie Voivodeship 62-065 Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field